Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.

Kaplan RC, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Parrinello CM, Benning L, Tracy RP.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):359-68. doi: 10.1097/QAI.0b013e31825b03be.

2.

[Carotid artery disease and human immunodeficiency virus (HIV) infection].

Serna-Candel C, Portilla J, Matías-Guiu J.

Neurologia. 2009 Jun;24(5):318-30. Review. Spanish.

PMID:
19642035
3.

Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic Review.

Vos AG, Idris NS, Barth RE, Klipstein-Grobusch K, Grobbee DE.

PLoS One. 2016 Jan 25;11(1):e0147484. doi: 10.1371/journal.pone.0147484. eCollection 2016. Review.

4.

Current update on HIV-associated vascular disease and endothelial dysfunction.

Mu H, Chai H, Lin PH, Yao Q, Chen C.

World J Surg. 2007 Apr;31(4):632-43. Review.

PMID:
17372667
5.

Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients.

Funderburg NT.

Curr Opin HIV AIDS. 2014 Jan;9(1):80-6. doi: 10.1097/COH.0000000000000019. Review.

6.

Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond.

Longenecker CT, Hoit BD.

Transl Res. 2012 Mar;159(3):127-39. doi: 10.1016/j.trsl.2011.10.007. Epub 2011 Nov 13. Review.

PMID:
22340762
7.

Cardiovascular Complications of HIV-Associated Immune Dysfunction.

Zaaqoq AM, Khasawneh FA, Smalligan RD.

Cardiol Res Pract. 2015;2015:302638. doi: 10.1155/2015/302638. Epub 2015 Jan 11. Review.

8.

Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation.

Swartz TH, Dubyak GR, Chen BK.

Front Immunol. 2015 Nov 26;6:585. doi: 10.3389/fimmu.2015.00585. eCollection 2015. Review.

Supplemental Content

Support Center